FX.co ★ EyePoint Pharma CMO Dario Paggiarino Quits, Ramiro Ribeiro Named Replacement

EyePoint Pharmaceuticals, Inc. (EYPT) stated on Monday that Dario Paggiarino, its Chief Medical Officer, has decided to resign from his given post. Paggiarino's role will now be taken over by Ramiro Ribeiro, a seasoned retinal specialist. Ribeiro carries a solid professional history of working with Apellis Pharmaceuticals as the Vice President of Clinical Development. In the pre-market activity report, it was noted that EyePoint Pharma shares were trading at $28.36 on the Nasdaq, showing an increase of 1.29%.